Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bar Code Rule Unintended Effects? Market May Demand Unit Dose Packaging

Executive Summary

Drug manufacturers are concerned that FDA's proposed bar code labeling rule would compel them to shift to coded unit dose packages

You may also be interested in...



FDA Bar Coding Final Rule Sets Two-Year Implementation Timeline

FDA's pharmaceutical bar coding final rule has a shorter implementation timeline than the agency previously proposed

FDA Bar Coding Final Rule Sets Two-Year Implementation Timeline

FDA's pharmaceutical bar coding final rule has a shorter implementation timeline than the agency previously proposed

FDA Bar Code Proposal Requires NDC; Lot, Expiration Date Not Cost Effective

FDA's proposed bar code rule does not require that the lot number or expiration date be encoded on product packaging because it has not been shown to be cost effective

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel